Elos Medtech’s dividend policy stipulates that the dividend is to be based on the Group’s earnings performance, while taking into account its future development potential and financial position. The long-term goal is for the dividend to increase at a constant rate and to be equivalent to 30-50 per cent of the profit after tax.
Share tickerShare Information
Press releases / Regulatory information
February 22, 2018
Year-end report for 2017
Annual report for 2017
April 24, 2018
Interim report January – March 2018